technology

Court bars US Apple Watch imports during appeal over ban


Apple on Wednesday failed to convince a federal appeals court to allow U.S. imports of Apple Watches with technology for reading blood-oxygen levels while it challenges a government tribunal’s decision that the devices infringe patents belonging to medical technology company Masimo.

The ruling by the U.S. Court of Appeals for the Federal Circuit means the affected watches cannot be imported while Apple appeals the underlying ban issued by the U.S. International Trade Commission.

Elevate Your Tech Prowess with High-Value Skill Courses

Offering College Course Website
Indian School of Business ISB Professional Certificate in Product Management Visit
Indian School of Business ISB Product Management Visit
IIM Kozhikode IIMK Senior Management Programme Visit

The ITC‘s import ban on Series 9 and Ultra 2 Apple Watches briefly went into effect on Dec. 26. The Federal Circuit lifted the ban on Dec. 27 while it considered Apple’s request for a long-term pause, and Apple resumed sales of the smartwatches later that day.

Separately, U.S. Customs and Border Protection on Jan. 12 determined that a proposed redesign from Apple would allow it to import reconfigured Apple Watches without violating the ITC’s restrictions, court filings show.

Masimo has accused Apple of hiring away its employees and stealing its pulse oximetry technology to use in Apple Watches. The ITC barred imports and direct Apple sales of Apple Watches that read blood-oxygen levels following a Masimo complaint.

Apple stopped selling its latest Series 9 and Ultra 2 watches in the United States before Christmas until the appeals court’s temporary pause. The devices remained available from other U.S. retailers including Amazon.com, Best Buy , Costco and Walmart.


Apple asked the Washington-based Federal Circuit to keep the ban on hold for the duration of the appeals process, which is likely to take months. It argued that it was likely to win its appeal and that keeping the ban in effect would harm the company, its suppliers and the public. The commission countered that Apple’s arguments “amount to little more” than a patent infringer “requesting permission to continue infringing.”

Apple has included a pulse oximeter feature in smartwatches since its Series 6 Apple Watch in 2020. It has countersued Masimo for patent infringement, calling Masimo’s legal actions a “maneuver to clear a path” for its own competing watch.

Apple Watches make up about a quarter of the global smartwatch market, according to Counterpoint Research. An Apple company report said its wearables, home and accessory business, which includes the Apple Watch, AirPods earbuds and other products, brought in $8.28 billion in revenue during the third quarter of 2023.

Stay on top of technology and startup news that matters. Subscribe to our daily newsletter for the latest and must-read tech news, delivered straight to your inbox.



READ SOURCE

This website uses cookies. By continuing to use this site, you accept our use of cookies.